Quest Diagnostics (DGX)
(Delayed Data from NYSE)
$149.85 USD
-0.92 (-0.61%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $149.80 -0.05 (-0.03%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Quest Diagnostics Incorporated [DGX]
Reports for Purchase
Showing records 441 - 460 ( 598 total )
Company: Quest Diagnostics Incorporated
Industry: Medical - Outpatient and Home Healthcare
Optimism Continues to Build and Build (and Build and Build)
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Quest Diagnostics Incorporated
Industry: Medical - Outpatient and Home Healthcare
Company: Quest Diagnostics Incorporated
Industry: Medical - Outpatient and Home Healthcare
Life Sciences And Healthcare IT: Making the FDA Great Again
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Quest Diagnostics Incorporated
Industry: Medical - Outpatient and Home Healthcare
Healthcare IT, Biopharmaceutical Services and Laboratories: Post-4Q16 Model Book
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Quest Diagnostics Incorporated
Industry: Medical - Outpatient and Home Healthcare
Company: Quest Diagnostics Incorporated
Industry: Medical - Outpatient and Home Healthcare
Company: Quest Diagnostics Incorporated
Industry: Medical - Outpatient and Home Healthcare
Company: Quest Diagnostics Incorporated
Industry: Medical - Outpatient and Home Healthcare
Company: Quest Diagnostics Incorporated
Industry: Medical - Outpatient and Home Healthcare
Management Provides in Line 2017 Outlook and the Shares Move Ever Higher
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Quest Diagnostics Incorporated
Industry: Medical - Outpatient and Home Healthcare
Research Summary
Provider: KEYBANC CAPITAL MARKETS